The SAVE (2016) data challenged whether CPAP meaningfully reduces hard cardiovascular endpoints in sleep apnea. How does this affect your counseling and follow-up intensity for patients who are CPAP-intolerant, and does it change how aggressively you pursue alternative treatments?